Although direct studies in ischemia are lacking, findings from HDAC-inhibitor-driven regulation of other T cell subsets (Tregs and Th17) imply that HDAC6 may similarly govern CD8+-mediated immune responses. The gene discussed is CD8A; the disease is ischemia.